Home
About
HTA Compass
Blog
Podcast
Contact Us
Home
About
HTA Compass
Blog
Podcast
Contact Us
Blog
Rethinking JCA Readiness: Why BioPharma Needs Smarter Tools, Not Just More Consulting Projects
Sep 23, 2025
Two Worlds in Pharma Value Chain - Two Adoption Stories
Sep 25, 2025
Building Smarter Evidence: How One ATMP Company Future, Proofed Its Market Access Strategy
Sep 26, 2025
From Cost to Value: How to embed Value-Based Pricing into Launch Strategy
Sep 30, 2025
Building Credible, Relevant, and Timely Evidence in Oncology: How a Pharma Company Aligned Strategy Across an Alliance
Sep 30, 2025
Rethinking Evidence Generation for In-Licensed Assets: A Case from Follicular Lymphoma
Sep 30, 2025
Cracking the European Market: How a US Biotech Navigated HTA and Reimbursement for Its First Launch
Sep 30, 2025
Building Pricing Discipline in Gene Therapy: How SOPs Strengthened Global Market Access
Sep 30, 2025
